NX Development Corp Seeks FDA Approval For MEN-301 Study
06 Apr 2026 //
PHARMIWEB
Gleolan(R) sales and marketing rights return to NX Development
24 Apr 2025 //
ACCESSWIRE
NX Enrolls First Patient in OVA-302 Study After FDA Orphan Designation
21 Jun 2024 //
ACCESSWIRE

Market Place
Sourcing Support